卡瑞利珠單抗聯(lián)合順鉑誘導(dǎo)食管鱗癌Eca-109細(xì)胞凋亡的研究

打開文本圖片集

中圖分類號(hào)：R735.1 文獻(xiàn)標(biāo)志碼：A DOI：10.3969/j.issn.1007-7146.2025.03.010

Abstract：Inorder to study the effctofcarilizumabcombined with cisplatinonapoptosis of esophagealsquamous cell carcinoma celsEca-109byregulating mitochondrialoxidative phosphorylation （OXPHOS）andphosphatidylinositol3 kiase/ proteinkinaseB（PI3K/AKT）signaling pathway，andtoobservetheexpresionofheatshock proteinA9（HSPA9）.Inthis study， the test was divided into blank control group，cisplatin group （100μmol/L ）and combined administration group which is cisplatin （100μmol/L）? +carrilizumab 200mg/time ）.Transwell migration test，scratch test，cell counting kit8（CCK-8） test andclonalaggregation technique were used toobserve the effectsofcarrelizumabcombined with cisplatinontheinvasion， migrationand proliferationof esophagealsquamouscellcarcinomacelsEca-19.The expressionofHSPA9gene wasdetected by RT-PCR. Westernblot（WB）was used to detect the expresion ofOXPHOS and PI3K/AKTpathway proteins.Mitochondrial reactiveoxygenspecies （ROS）were detected byflowcytometry.Transwellmigration，scratchtest，CCK-8 testandclonal formationtestshowedthatthecombinedadministrationgroupihbitedtheactivitymigrationandaggregationofEca-O9cells more than the cisplatin group.Reverse transcription-polymerase chain reaction （RT-PCR）and WB detectionresults showed that compared with cisplatin group and control group，the expresion of HSPA9 and OXPHOS in combined administration group significantly decreased，and the phosphorylation of PI3K/AKTwas inhibited （P<0.01 ）. Flow cytometry showed that compared withcontrolgroupandcisplatin group，ROSlevelsincisplatin+carilizumab groupsignificantly increased，andtherewas a significantdifference ?P<0.05 ）.Compared with cisplatinalone，carrellizumabcombined with cisplatincould significantly inhibit the expressionofHSPA9andOXPHOS inesophagealsquamous cellcancercells，ihibit thephosphorylationofPI3K/ AKTsignalingpathwayandregulatereoxidationandmitochondrialhomeostasis.TheinhibitionofEca-1O9onesophageal squamous cellcarcinoma by inducing mitochondrial apoptosis provides a reference forthe precise interventionandtreatmentof esophageal squamous cell carcinoma in clinical practice.

Key words： carrilizumab; cisplatin; esophageal squamouscell carcinoma; OXPHOS; HSPA9 （ActaLaser Biology Sinica，2025，34（3）：274-281）

食管癌（esophagealcancer）是臨床上發(fā)病率較高、惡性程度較高的一類消化道腫瘤，因臨床癥狀較隱匿，早期不容易被及時(shí)發(fā)現(xiàn)，等出現(xiàn)臨床癥狀時(shí)已是中晚期。（剩余12817字）